Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial
Lak, Kim Khemarin
Goldfeld, Anne E
MetadataShow full item record
JournalClinical Infectious Diseases : an official publication of the Infectious Diseases Society of America
AbstractShortening the interval between antituberculosis treatment onset and initiation of antiretroviral therapy (ART) reduces mortality in severely immunocompromised human immunodeficiency virus (HIV)-infected patients with tuberculosis. A better understanding of causes and determinants of death may lead to new strategies to further enhance survival.
PublisherOxford University Press